1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, November 2016 (p6)

Biological Therapy Analysis & Statistics, November 2016 (p6)

24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

151-180 of about 900 reports

Purchase Reports From Reputable Market Research Publishers

Uveitis Global Clinical Trials Review, H2, 2016

Uveitis Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • November 2016
  • by GlobalData

Uveitis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Uveitis Global Clinical Trials Review, H2, 2016" provides an overview of Uveitis clinical trials scenario. ...

  • Industries : Therapy, Drug Discovery and Development, Pharmaceutical
  • Countries : World
Liver Fibrosis Global Clinical Trials Review, H2, 2016

Liver Fibrosis Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • November 2016
  • by GlobalData

Liver Fibrosis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Liver Fibrosis Global Clinical Trials Review, H2, 2016" provides an overview of Liver Fibrosis clinical ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World
Eosinophilic Esophagitis Global Clinical Trials Review, H2, 2016

Eosinophilic Esophagitis Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • November 2016
  • by GlobalData

Eosinophilic Esophagitis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Eosinophilic Esophagitis Global Clinical Trials Review, H2, 2016" provides an overview of ...

  • Industries : Therapy, Pathology, Pharmaceutical, Biological Therapy, Healthcare
  • Countries : World
Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Pipeline Review, H2 2016

Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Pipeline Review, H2 2016 Summary Global Markets ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States
HIV 1 Integrase (EC 2.7.7.) - Pipeline Review, H2 2016

HIV 1 Integrase (EC 2.7.7.) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

HIV 1 Integrase (EC 2.7.7.) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘HIV 1 Integrase (EC 2.7.7.) - Pipeline Review, H2 2016’, provides in depth analysis on HIV 1 Integrase (EC ...

  • Industries : Therapy
  • Countries : United States
Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H2, 2016

Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • November 2016
  • by GlobalData

Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H2, 2016" ...

  • Industries : Drug Discovery and Development, Pharmaceutical, General Medicine and Specialty Medicine, Pathology
  • Countries : World
Fatigue Global Clinical Trials Review, H2, 2016

Fatigue Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • November 2016
  • by GlobalData

Fatigue Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Fatigue Global Clinical Trials Review, H2, 2016" provides an overview of Fatigue clinical trials scenario. ...

  • Industries : Therapy, Pharmaceutical
  • Countries : World
Hepatocellular Carcinoma - Pipeline Review, H2 2016

Hepatocellular Carcinoma - Pipeline Review, H2 2016

  • $ 2500
  • Company report
  • November 2016
  • by Global Markets Direct

Hepatocellular Carcinoma - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Hepatocellular Carcinoma - Pipeline Review, H2 2016, provides ...

  • Industries : Pathology, Healthcare
  • Countries : United States
Stroke - Pipeline Review, H2 2016

Stroke - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Stroke - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Stroke – Pipeline Review, H2 2016, provides an overview of the Stroke (Cardiovascular) ...

  • Industries : Pathology, Chronic Disease
  • Countries : United States
International Stem Cell Corp (ISCO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

International Stem Cell Corp (ISCO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2016
  • by GlobalData

Summary International Stem Cell Corp (ISCC) is a biotechnology company that develops technology solutions. The company develops parthenogenesis, which is a stem cell technology that improves the field ...

  • Industries : Biological Therapy
Integrated BioTherapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Integrated BioTherapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2016
  • by GlobalData

Summary Integrated BioTherapeutics Inc (IBT) is a biotechnology company that discovers novel vaccines and therapeutics for infectious diseases. Its pipeline products include vaccines and therapeutics against ...

  • Industries : Pathology
  • Countries : United States
Japan Tissue Engineering Co Ltd (7774) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Japan Tissue Engineering Co Ltd (7774) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2016
  • by GlobalData

Summary Japan Tissue Engineering Co Ltd (J-TEC) is a bio-venture company that develops, manufactures and sells tissue-engineered medical products and related products. The company's products include autologous ...

  • Countries : Japan
2016-2021  World Cell Surface Marker Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan--Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities

2016-2021 World Cell Surface Marker Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan--Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities

  • $ 3500
  • Industry report
  • November 2016
  • by Venture Planning Group

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic ...

  • Industries : Biological Therapy
  • Countries : United States, Spain, France, Italy, United Kingdom, Japan
2016-2021  US Cell Surface Marker Testing Market: Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities

2016-2021 US Cell Surface Marker Testing Market: Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities

  • $ 1450
  • Industry report
  • November 2016
  • by Venture Planning Group

Complete report $2,050.  DataPack (test volumes, sales forecasts, supplier shares) $1,450. Rationale The use of surface marker identification and classification of cells is spreading beyond lymphocytes ...

  • Industries : Biological Therapy
  • Countries : United States
U.S. Stem Cell Inc (USRM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

U.S. Stem Cell Inc (USRM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2016
  • by GlobalData

Summary U.S. Stem cell Inc (U.S. Stem cell), formerly Bioheart, Inc, is a biotechnology company which focuses on the discovery, development and commercialization of cell based therapeutics products. The ...

  • Industries : Biological Therapy
  • Countries : United States
Oncology drugs report - Neupogen and Neulasta - filgrastim franchise - 1991-2015 analysis; 2016-2021 expectations

Oncology drugs report - Neupogen and Neulasta - filgrastim franchise - 1991-2015 analysis; 2016-2021 expectations

  • $ 1000
  • Industry report
  • November 2016
  • by Cancer Research Analytics

“Oncology drugs report - Neupogen and Neulasta - filgrastim franchise - 1991-2015 analysis; 2016-2021 expectations” is a comprehensive report on Neupogen and Neulasta, two market leading drugs (by ...

  • Industries : Biotechnology, Biological Therapy, Biopharmaceutical, Generic Drug, Pharmaceutical, Therapy
  • Countries : Japan, Asia
Global Next-Generation Biologics Market 2016-2020

Global Next-Generation Biologics Market 2016-2020

  • $ 2500
  • Industry report
  • November 2016
  • by Infiniti Research Limited

About Next-generation Biologics According to the section 351 of the Public Health Service Act of the US FDA, a biological product is defined as a “virus, therapeutic serum, antitoxin, vaccine, toxin, ...

  • Industries : Biological Therapy, Therapy, Biotechnology
  • Countries : World, United States
Northwest Biotherapeutics Inc (NWBO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Northwest Biotherapeutics Inc (NWBO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2016
  • by GlobalData

Summary Northwest Biotherapeutics Inc (NW Bio) is a development stage biotechnology company. It discovers and develops immunotherapy products to treat cancer in an effective way without toxicities associated ...

  • Industries : Biological Therapy, Cancer, Pathology
Tissue Therapies Ltd (FTT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Tissue Therapies Ltd (FTT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2016
  • by GlobalData

Summary Tissue Therapies Ltd (FTL), formerly Tissue Therapies Ltd, which focuses on the development and commercialization of advanced wound care therapeutics. The company develops treatments for acute ...

  • Industries : Biological Therapy
High-Throughput Screening Market by Technology, Application, Product, End User - Forecast to 2021

High-Throughput Screening Market by Technology, Application, Product, End User - Forecast to 2021

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

The high-throughput screening (HTS) market is expected to grow at a lucrative CAGR of 7.8% from 2016 to 2021, to reach USD 18.83 billion by 2021 from USD 12.23 billion in 2016. Market growth can be attributed ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : Europe, World, North America, United States, Asia
California Institute for Regenerative Medicine - Pharmaceuticals & Healthcare - Deals and Alliances Profile

California Institute for Regenerative Medicine - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2016
  • by GlobalData

Summary California Institute for Regenerative Medicine (CIRM) is a medical research service provider that makes grants and offers loans for stem cell research, facilities and other opportunities. The organization ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : United States
Spinal Cord Injury - Pipeline Review, H2 2016

Spinal Cord Injury - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Spinal Cord Injury - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Spinal Cord Injury – Pipeline Review, H2 2016, provides an overview ...

  • Industries : Mental Health, Pathology
  • Countries : United States
Stromal Cell Derived Factor 1 (C-X-C Motif Chemokine 12 or Intercrine Reduced In Hepatomas or SDF1 or Pre B Cell Growth Stimulating Factor or CXCL12) - Pipeline Review, H2 2016

Stromal Cell Derived Factor 1 (C-X-C Motif Chemokine 12 or Intercrine Reduced In Hepatomas or SDF1 or Pre B Cell Growth Stimulating Factor or CXCL12) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Stromal Cell Derived Factor 1 (C-X-C Motif Chemokine 12 or Intercrine Reduced In Hepatomas or SDF1 or Pre B Cell Growth Stimulating Factor or CXCL12) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ...

  • Industries : Cancer, Pathology, Biological Therapy
  • Countries : United States
Cytomegalovirus (HHV-5) Infections - Pipeline Review, H2 2016

Cytomegalovirus (HHV-5) Infections - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Cytomegalovirus (HHV-5) Infections - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cytomegalovirus (HHV-5) Infections – Pipeline ...

  • Industries : Pathology, Healthcare
  • Countries : United States
Osteonecrosis - Pipeline Review, H2 2016

Osteonecrosis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Osteonecrosis - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteonecrosis – Pipeline Review, H2 2016, provides an overview of ...

  • Industries : Therapy
  • Countries : United Kingdom, World
Global 3D Bioprinting Market Size, Share, Development, Growth and Demand Forecast to 2022 - Industry Insights by Technology, by Application

Global 3D Bioprinting Market Size, Share, Development, Growth and Demand Forecast to 2022 - Industry Insights by Technology, by Application

  • $ 5100
  • Industry report
  • November 2016
  • by P&S Market Research

3D bioprinting refers to the process of creating 3D structures using live cells. The process uses 3D printing technologies for crating live cells or tissue structures. These structures are used for applications ...

  • Industries : Biological Therapy
  • Countries : China, World
Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H2 2016

Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Fibroblast Growth ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States
Natural Killer Cells- Competitive Landscape, Technology and Pipeline Analysis, 2016

Natural Killer Cells- Competitive Landscape, Technology and Pipeline Analysis, 2016

  • $ 1950
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s, “Natural Killer Cells- Competitive Landscape, Technology and Pipeline Analysis, 2016”, report provides comprehensive insights about pipeline drugs across this indication. Key objective ...

  • Industries : Biological Therapy
Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2016

Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Type 1 Diabetes (Juvenile Diabetes) – Pipeline ...

  • Industries : Pathology, Chronic Disease
  • Countries : United States
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2016

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Lymphocytic Leukemia ...

  • Industries : Cancer, Pathology
  • Countries : United States

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.